KATNBL1P6: A Potential Drug Target and Biomarker (G729176)

Target Name: KATNBL1P6

NCBI ID: G729176

KATNBL1P6

Other Name(s): katanin regulatory subunit B1 like 1 pseudogene 6 | Katanin regulatory subunit B1 like 1 pseudogene 6

KATNBL1P6: A Potential Drug Target and Biomarker

KATNBL1P6 is a gene that encodes for the katanin regulatory subunit B1-like 1 pseudogene 6. This gene is located on chromosome 16 and has been identified as a potential drug target and biomarker.

The katanin gene is a member of the TATA-binding protein (TBP) gene family, which is known for their role in regulating gene expression. The katanin gene encodes for a protein that plays a critical role in the regulation of mitochondrial function and energy metabolism. This protein is also known as katanin, and it functions as a negative regulator of the mitochondrial inner mitochondrial membrane protein ( Inner membrane protein, IMP ) gene.

The katanin gene has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and developmental disorders. For example, studies have shown that high levels of katanin are associated with an increased risk of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. Additionally, high levels of katanin have also been linked to an increased risk of cancer, particularly breast and ovarian cancers.

In addition to its potential health implications, KATNBL1P6 has also been identified as a potential drug target. The katanin gene has been shown to be highly conserved across species, which suggests that it may be a good candidate for small molecule inhibitors. Additionally, the katanin gene is located on chromosome 16, which is a common target site for cancer drugs.

One potential drug that may target KATNBL1P6 is a small molecule inhibitor that targets the katanin gene. This drug could be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Another potential application of KATNBL1P6 as a drug target is as a biomarker. The katanin gene has been shown to be expressed in a variety of tissues and cells, including brain, muscle, and blood cells. This makes it a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

In conclusion, KATNBL1P6 is a gene that has the potential to be a drug target and biomarker. The katanin gene is known for its role in regulating mitochondrial function and energy metabolism, and it has been implicated in a number of diseases. Additionally, the katanin gene is located on chromosome 16, which makes it a common target site for cancer drugs. Further research is needed to determine the full potential of KATNBL1P6 as a drug target and biomarker.

Protein Name: Katanin Regulatory Subunit B1 Like 1 Pseudogene 6

The "KATNBL1P6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KATNBL1P6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets